Lantheus Medical Imaging Overview

  • Year Founded
  • 1956

Year Founded

  • Status
  • Public

  • Employees
  • 834

Employees

  • Stock Symbol
  • LNTH

Stock Symbol

  • Investments
  • 7

  • Share Price
  • $87.50
  • (As of Friday Closing)

Lantheus Medical Imaging General Information

Description

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Contact Information

Formerly Known As
Bristol-Myers Squibb Medical Imaging, New England Nuclear Corporation, New England Nuclear, Lantheus Mi Holdings, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 201 Burlington Road
  • South Building
  • Bedford, MA 01730
  • United States
+1 (800)
Primary Industry
Other Devices and Supplies
Other Industries
Diagnostic Equipment
Stock Exchange
NAS
Corporate Office
  • 201 Burlington Road
  • South Building
  • Bedford, MA 01730
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lantheus Medical Imaging Stock Performance

As of 08-Nov-2024, Lantheus Medical Imaging’s stock price is $87.50. Its current market cap is $6.08B with 69.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$87.50 $88.31 $50.20 - $126.89 $6.08B 69.5M 794K $6.21

Lantheus Medical Imaging Financials Summary

As of 30-Sep-2024, Lantheus Medical Imaging has a trailing 12-month revenue of $1.5B.

In Thousands,
USD
TTM 30-Sep-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 7,481,176 4,247,892 3,433,207 2,041,203
Revenue 1,496,799 1,296,429 935,061 425,208
EBITDA 617,007 470,924 78,191 (26,631)
Net Income 427,612 326,661 28,067 (71,279)
Total Assets 2,049,630 1,651,149 1,321,258 863,784
Total Debt 619,241 616,946 583,508 191,309
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Lantheus Medical Imaging Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lantheus Medical Imaging‘s full profile, request access.

Request a free trial

Lantheus Medical Imaging Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its pro
Other Devices and Supplies
Bedford, MA
834 As of 2023

Chicago, IL
 

Billerica, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Lantheus Medical Imaging Competitors (7)

One of Lantheus Medical Imaging’s 7 competitors is GE HealthCare Technologies, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GE HealthCare Technologies Corporation Chicago, IL
Bruker Formerly VC-backed Billerica, MA
Bio-Rad Laboratories Corporation Hercules, CA
Guerbet Group Corporation Villepinte, France
Life Molecular Imaging Corporate Backed or Acquired Berlin, Germany
You’re viewing 5 of 7 competitors. Get the full list »

Lantheus Medical Imaging Patents

Lantheus Medical Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023217725-A1 Gas nano/micro-bubble compositions and uses thereof Pending 09-Feb-2022
AU-2021322205-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020
CA-3189851-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020
EP-4192611-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020
US-20230270412-A1 Methods and devices for preparation of ultrasound contrast agents Pending 04-Aug-2020 A61K49/223
To view Lantheus Medical Imaging’s complete patent history, request access »

Lantheus Medical Imaging Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lantheus Medical Imaging Investments & Acquisitions (7)

Lantheus Medical Imaging’s most recent deal was a Corporate Asset Purchase with Lantheus Holdings (Global Rights to Life Molecular Imaging's RM2 Product) for . The deal was made on 28-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lantheus Holdings (Global Rights to Life Molecular Imaging's RM2 Product) 28-Jun-2024 Corporate Asset Purchase Buildings and Property
Radiopharm Theranostics 20-Jun-2024 PIPE Drug Discovery
Meilleur Technologies 18-Jun-2024 Merger/Acquisition Discovery Tools (Healthcare)
Cerveau Technologies 06-Feb-2023 Merger/Acquisition Discovery Tools (Healthcare)
Ratio Therapeutics 02-Feb-2023 Early Stage VC Biotechnology
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Lantheus Medical Imaging Subsidiaries (3)

Company Name Industry Location Founded
Meilleur Technologies Discovery Tools (Healthcare) Dublin, OH 2018
Cerveau Technologies Discovery Tools (Healthcare) Knoxville, TN
Lantheus Medical Imaging Retirement Savings Plan Corporate Pension North Billerica, MA
To view Lantheus Medical Imaging’s complete subsidiaries history, request access »

Lantheus Medical Imaging ESG

Risk Overview

Risk Rating

Updated October, 15, 2024

33.06 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,035

Rank

Percentile

Pharmaceuticals

Industry

of 847

Rank

Percentile

Pharmaceuticals

Subindustry

of 423

Rank

Percentile

To view Lantheus Medical Imaging’s complete esg history, request access »

Lantheus Medical Imaging FAQs

  • When was Lantheus Medical Imaging founded?

    Lantheus Medical Imaging was founded in 1956.

  • Where is Lantheus Medical Imaging headquartered?

    Lantheus Medical Imaging is headquartered in Bedford, MA.

  • What is the size of Lantheus Medical Imaging?

    Lantheus Medical Imaging has 834 total employees.

  • What industry is Lantheus Medical Imaging in?

    Lantheus Medical Imaging’s primary industry is Other Devices and Supplies.

  • Is Lantheus Medical Imaging a private or public company?

    Lantheus Medical Imaging is a Public company.

  • What is Lantheus Medical Imaging’s stock symbol?

    The ticker symbol for Lantheus Medical Imaging is LNTH.

  • What is the current stock price of Lantheus Medical Imaging?

    As of 08-Nov-2024 the stock price of Lantheus Medical Imaging is $87.50.

  • What is the current market cap of Lantheus Medical Imaging?

    The current market capitalization of Lantheus Medical Imaging is $6.08B.

  • What is Lantheus Medical Imaging’s current revenue?

    The trailing twelve month revenue for Lantheus Medical Imaging is $1.5B.

  • Who are Lantheus Medical Imaging’s competitors?

    GE HealthCare Technologies, Bruker, Bio-Rad Laboratories, Guerbet Group, and Life Molecular Imaging are some of the 7 competitors of Lantheus Medical Imaging.

  • What is Lantheus Medical Imaging’s annual earnings per share (EPS)?

    Lantheus Medical Imaging’s EPS for 12 months was $6.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »